Quantcast

Latest autoimmune disease Stories

2009-03-11 14:35:00

Grammy Award-winning singer advocates for research into disease afflicting 7.5 million Americans WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Grammy Award-winning artist LeAnn Rimes shared her personal story on Capitol Hill today about growing up with psoriasis, and she encouraged lawmakers to support much-needed research and enact legislation to address this complex, autoimmune disease. "I was first diagnosed with psoriasis at age 2 and throughout my childhood, my condition worsened to...

2009-03-03 01:00:00

LONDON, March 3 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Aesku.Diagnostics with the 2008 European Frost & Sullivan Product Line Strategy Award for its consistent approach towards product development. It has anticipated and catered to the needs in bio-marker identification, offered versatile immunoassay systems, extended research capabilities as well as delivered unprecedented sensitivity and exceptional...

2009-01-24 14:30:47

Scientists at UCSF have discovered an abnormality in a patient's immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection. The research identified antibodies from a woman's immune system that prevent infection-fighting T cells from moving through her blood stream and entering her body's organs to attack invaders such as bacteria or viruses. Findings appear in the current online...

2009-01-15 09:00:00

CAMBRIDGE, Mass., Jan. 15 /PRNewswire/ -- Peptimmune, Inc. ("Peptimmune"), a privately held biotechnology company, announced today that it has granted Novartis (NYSE: NVS) an exclusive option to obtain exclusive worldwide rights to develop and commercialize PI-2301, Peptimmune's multiple sclerosis drug candidate. In a separate but related agreement, the MPM Bio IV NVS Strategic Fund L.P. made an equity investment in Peptimmune. In the event that Novartis exercises the option to PI-2301,...

2008-10-28 12:00:17

Seattle Genetics, Inc. (Nasdaq: SGEN) today presented preclinical data on SGN-70 at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco, California. SGN-70 is a humanized monoclonal antibody targeting CD70 that is in development as a novel therapy for autoimmune diseases. Seattle Genetics is currently conducting a phase I trial to assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. "CD70 is an ideal target for...

2008-10-16 09:00:43

Research and Markets (http://www.researchandmarkets.com/research/37e728/autoimmune_disease) has announced the addition of the "Autoimmune Disease Therapeutics" report to their offering. As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until...

2008-09-19 12:00:10

Maxygen and Astellas Pharma have announced a global agreement under which Astellas will receive worldwide rights to commercialize Maxy-4 lead candidates for all autoimmune diseases and transplant rejection. Under the agreement, the companies will co-develop Maxy-4 candidates for rheumatoid arthritis and other autoimmune diseases and Astellas will exclusively develop Maxy-4 candidates for transplant rejection. In addition, Maxygen has an option to co-promote any autoimmune therapeutic...

2008-08-28 21:00:13

By Mike Waites Health Correspondent The killer cells are part of the body's immune system which have been shown to destroy cancers in the test tube.But the cells also produce chemicals which direct the activity of other parts of the immune system, effectively sounding an alarm directing the body to attack infections.Now a research team from York University's Centre for Immunology and Infection has shown for the first timer that the cells also do the opposite and make chemicals which can...

2008-08-13 12:00:18

By SUZY COHEN Q: I have MS and I've taken the medicine Copaxone. Last year, you said not to rev up my immune system with vitamins. Can you explain why and tell me what kinds of supplements are safe? -- R.T., Decatur,Ill. A: Imagine looking into the mirror, but instead of seeing your sweet self, you see a creepy robber and then start punching yourself -- and it hurts. That's autoimmune disease -- your immune system perceives its own tissue as an invader, then seeks to destroy it, little...

2008-07-31 09:01:26

Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune diseases. The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. "CD70 targeted therapies have shown promise in multiple preclinical models by reducing autoimmune disease activity at well-tolerated doses," said Thomas C....


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related